NEW YORK CITY, NY / ACCESS Newswire / January 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger ...
Clearwater Analytics acquires Enfusion for $1.5 billion, enhancing portfolio management and SaaS revenue growth. Click here ...
NEW YORK CITY, NY / ACCESS Newswire / January 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Enfusion, ...
Enfusion, Inc. (NYSE: ENFN)’s sale to Clearwater Analytics for $5.85 per share in cash and $5.40 per share in Clearwater Class A Common Stock. If you are an Enfusion shareholder, click here to ...
NEW YORK, Jan. 28, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...
NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Buy ENFN near 10.89 target n/a stop loss @ 10.86. Details The technical summary data tells us to buy ENFN near 10.89, but there is no current upside target from the summary table. In this case we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback